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Background—Sexual transmission rates of Chlamydia trachomatis (Ct) cannot be measured 
directly; however, the study of concordance of Ct infection in sexual partnerships (dyads) can help 
to illuminate factors influencing Ct transmission.
Methods—Heterosexual men and women with Ct infection and their sex partners were enrolled 
and partner-specific coital and behavioral data collected for the prior 30 days. Microbiological data 
included Ct culture, nucleic acid amplification testing (NAAT), quantitative Ct polymerase chain 
reaction (qPCR), and ompA genotyping. We measured Ct concordance in dyads, and factors 
(correlates) associated with concordance.
Results—121 women and 125 men formed 128 dyads. Overall, 72.9% of male partners of 
NAAT-positive women and 68.6% of female partners of NAAT-positive men were Ct-infected. 
Concordance was more common in dyads with culture-positive members (78.6% of male partners, 
77% of female partners). Partners of women and men who were NAAT-positive only had lower 
concordance (33.3%, 46.4%, respectively). Women in concordant dyads had significantly higher 
median endocervical qPCR values (3,032) compared with CT-infected women in discordant dyads 
(1,013 IFU DNA equivalents per ml), p<0.01. Among 54 Ct-concordant dyads with ompA 
genotype data for both members, 96.2% had identical genotypes.
Conclusions—Higher organism load appears associated with concordance among women. 
Same-genotype chlamydial concordance was high in sexual partnerships. No behavioral factors 
were sufficiently discriminating to guide partner services activities. Findings may help model 
coitus-specific transmission probabilities.
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INTRODUCTION
Chlamydia trachomatis (Ct) is the most common cause of bacterial sexually transmitted 
infections (STI), with 1.4 million cases reported in the U.S. in 2014 [1] and more than twice 
that number estimated to occur each year. Ct infection is associated with an increased risk of 
pelvic inflammatory disease, ectopic pregnancy and tubal infertility [2] but infection is 
usually asymptomatic and many cases are detected only by screening. Ct case rates have 
risen over the past decade [1], likely as a result of increased screening and widespread use of 
sensitive nucleic acid amplification tests (NAATs); however, population prevalence has 
decreased during the same period [3]. These seemingly contradictory observations may be 
related to the use of NAATs that detect infections with a lower organism-load than can be 
detected by culture or other non-amplified methods. If people with NAAT-positive, but 
culture negative infections (NAAT-only infections) pose a lower risk of transmission to their 
sex partners, incidence could increase at the same time population prevalence decreases.
Concordance studies of STI examine the extent to which sex partners are infected with the 
same STI (concordance); partnerships wherein only one member is infected are considered 
discordant. Robust predictors of Ct concordance in sex partnerships could be useful for 
prioritizing provider-led partner notification, an effective but resource-intensive intervention 
that involves eliciting the names and contact details for the sex partner(s) of a person with an 
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STI in order to notify them of their exposure and ensure testing and treatment. Because of 
the vast numbers of diagnosed chlamydial infections, provider-led partner notification is not 
widely used to identify sex partners of Ct-infected persons. Data from concordance studies 
with detailed coital and behavioral information specific to the sexual partnership could also 
be used to estimate the probability of Ct transmission per coital act.
Past Ct concordance studies have been limited by: small sample sizes, index cases of a 
single sex, diagnostic tests of low sensitivity, a limited number of specimen types, 
incomplete information regarding frequency, timing, and partner-specificity of coitus, and 
lack of biomarkers to establish that the strain in each infection-concordant partnership is the 
same [4-9, 31s-34s]. We conducted a multi-center sexual partnership study in Boston and 
Indianapolis to: examine biologic and behavioral correlates of Ct infection concordance 
using laboratory and data collection methods designed to overcome many of the limitations 
of previous concordance studies. We also sought to establish how often ompA genotypes 
were identical within a partnership and determine if partners of NAAT-positive, culture-
negative participants were less likely to be infected than the partners of culture-positive 
participants.
MATERIALS AND METHODS
Study population and study design
Participants were 14-24 year old heterosexual males and females infected with Ct and their 
opposite-sex, sex partners. The study was a cross-sectional design consisting of a single visit 
for each member of a partnership (referred to as a dyad). Participants were recruited between 
April 10, 2000 and September 29, 2003, at adolescent and sexually transmitted infection 
(STI) clinics in Boston, Massachusetts and Indianapolis, Indiana. The first dyad member to 
enroll was required to have a working knowledge of English and stated willingness to name 
all sex partners. Potential participants were excluded from enrollment if they had: taken 
antibiotics in the past 30 days, a known immunosuppressive condition, a clinic visit 
necessitated by sexual assault, evidence of an emotional or mental health crisis, or had 
previously enrolled in the study.
Study personnel interviewed enrollees found to be Ct–infected to elicit the names and 
locating information for sex partners during the 30 days before enrollment. Sex partners 
were sought for evaluation and treatment; they were subject to the same inclusion criteria as 
the first enrolled dyad member, and the same exclusion criteria, (with the exception that 
previous enrollment was permitted) and were offered study enrollment if they were age 14 or 
older.
Unit of analysis
The unit of analysis for this study was a sexual dyad that had at least one member infected 
with Ct. A study participant with multiple enrolled sex partners could contribute to more 
than one dyad.
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Data collection
Participants completed an enrollment questionnaire that collected basic demographics and a 
reproductive and sexual history. Study personnel used a standard script to administer sexual 
event-specific calendar interviews concerning sexual and other behaviors and events in the 
30 days before study enrollment, using a modification of the calendar-event method [10] 
previously applied to adolescent sexual behavior [11]. For each day, the interviewer 
ascertained the number of episodes of intercourse and recorded the initials of the sex partner 
for each coital event. Information was collected on coital event-specific behaviors including 
condom, spermicide use, and drug use in the two hours before sex.
Physical examination and specimen collection and testing
All participants were interviewed and had a detailed genital examination. Samples were 
obtained from each participant for detection of Ct (males: urethral swabs for both culture 
and NAAT, urine for NAAT; females: endocervical and urethral swabs for both culture and 
NAAT, and vaginal and urine specimens for NAAT), Neisseria gonorrhoeae (male urethral, 
and female endocervical swabs for culture), Trichomonas vaginalis (male urethral swabs and 
urine, and female vaginal swabs for NAAT), and bacterial vaginosis (BV) (high vaginal 
swabs).
Laboratory methods
NAATs—Ct was detected by polymerase chain reaction (PCR) (Amplicor, Roche 
Diagnostics) in Indianapolis, and by transcription-mediated amplification (TMA) (APTIMA, 
Gen-Probe) in Boston. T. vaginalis was detected using a modification of the Amplicor assay 
that included primers and probes specific for T. vaginalis [12].
Quantitative PCR for Chlamydia trachomatis—The number of Ct organisms in 
endocervical, and male urethral specimens (in IFU DNA equivalents per ml (IFUde), defined 
as the amount of Ct DNA obtained from a preparation containing one culturable organism 
(IFU) of strain ATCC VR-346 serovar F) were measured by quantitative asymmetric PCR 
(qPCR) using primers, CTR70 (5’ biotinylated, 25 picomoles) and CTR71 (1.25 picomoles) 
and a touchdown protocol that used annealing temperatures (62°C to 52°C) with 2.5 mM 
MgCl2 [13,14]. Amplicons were measured by colorimetric capture-probe ELISA type assay 
[15]. Four tenfold dilution controls (5,000 IFUde to 5 IFUde) and a negative control were 
placed in each run and their colorimetric values utilized to translate the values from positive 
Ct specimens into IFUde [15].
STI cultures—Cell culture for Ct was performed using procedures established in the 
Indianapolis and Boston laboratories at the time of the study [16,17]; Specimens for culture 
of N. gonorrhoeae were inoculated onto modified Thayer-Martin medium; isolation and 
identification were done according to standard laboratory procedures.
CtompA genotyping—DNA sequencing of PCR-amplified ompA from clinical samples 
was performed according to the methods of Stothard et al. [18,19]. PCR products were 
evaluated by a reverse dot blot to identify the presence of multiple serovars (eg, D and F) in 
study samples with the limitations that the procedure cannot distinguish between strains with 
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nucleotide polymorphisms (e.g., D and D6) and serovars I/Ia, and J/Ja that cross-react [20]. 
Sequences were not obtained on samples when two serovars were identified; therefore, strain 
identification for mixed infections was at the level of serovar, not genotype. We defined 
prototype and variant strains as previously described [18]
Other tests—Gram stains of high vaginal secretions were assessed for BV defined by a 
Nugent score of 4-6 with clue cells present, or by a Nugent score ≥ 7 [21].
Human subjects approval
Study participants were administered informed consent, and compensated $20-$25 for their 
time, and inconvenience. The study was approved by the Institutional Review Boards (IRBs) 
at: Indiana University School of Medicine, (Indianapolis, Indiana), Boston Medical Center 
and Boston Children's Hospital (Boston, Massachusetts), and the Centers for Disease 
Control and Prevention (Atlanta Georgia). The study was conducted in accordance with the 
ethical standards of the participating institutions’ IRBs, and in accordance with the standards 
of the Helsinki Declaration of 1975, as revised in 2000.
Data analysis
Definitions—We defined sexual dyads as a heterosexual sexual partnership wherein at 
least one member was Ct-infected. Participants who had any specimen test positive for Ct by 
any diagnostic test were considered infected.
Dyads with two Ct-infected members were considered concordant. Dyad members with 
incomplete test results were not excluded from Ct-concordancy analyses; however, they 
were excluded from analyses of the chlamydial ompA genotypes in concordant dyads, as 
were dyads in which infecting Ct detected in both members of a dyad were not both 
genotyped or when a dyad member had mixed Ct serovar infection (n=4).
Drug use before intercourse was defined as use of alcohol, marijuana, or other illicit drugs in 
the 2 hours before having sex. Men who reported discharge, dysuria, genital rash or itching 
or testicular pain, and women who reported vaginal discharge, dysuria, genital rash or 
itching or lower abdominal pain were considered to have had symptoms at the time of sex. 
Reported condom use was categorized as “100%” if a dyad member reported using a 
condom for every coital event with the other dyad member.
Partner-specific measures and outcomes: To examine the association between sexual 
behaviors and concordance, we only considered sexual events between enrolled dyad 
members. If dyad members enrolled on different days the analytic dataset included 
observations from each dyad member's full 30 day recall period (even if they had fewer than 
30 days in common during their respective recall periods).
Characteristics associated with concordance: We assessed characteristics associated with 
concordance using simple logistic regression models with generalized estimating equations 
(GEE) to account for correlations among dyads that shared a member. The strength of 
univariate associations were assessed by calculating odds ratios (OR); the GEE sandwich 
estimate for the standard errors was used to calculate 95% confidence intervals.
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To explore male factors that could be associated with having a Ct-infected female partner, 
we examined the association between the characteristics of Ct-infected males in concordant 
dyads using a comparison group of discordant dyads with Ct-infected males and uninfected 
females. To examine female factors associated with having an infected male partner, we 
compared the characteristics of females in concordant dyads to the characteristics of females 
in discordant dyads wherein the female was infected, but the male was not.
To explore male factors that could be associated with male susceptibility to Ct infection, we 
compared the characteristics of males in Ct-concordant dyads to those of males in discordant 
dyads wherein the female was infected but the male was not. Likewise, to examine female 
characteristics that could be associated with female susceptibility to Ct infection we 
compared the characteristics of females in concordant dyads to the characteristics of females 
in discordant dyads wherein the male was infected but the female was not. Log transformed 
qPCR values were used to calculate ORs measuring the association qPCR values and 
concordance.
RESULTS
Characteristics of study participants
Characteristics of the study population are presented in Table 1. A total of 121 women and 
125 men were enrolled, forming 128 dyads. Of these, 108 dyads were comprised of unique 
male and female members, and 20 dyads shared members (3 men contributed 2 dyads, and 7 
women contributed 2 dyads.)
Characteristics of dyads
In more than a third of dyads, both members enrolled on the same day (35.2%, 45/128); 
31.3% members (40/128) enrolled within 1-7 days, 19.5% (25/128) within 8-14 days, and 
14.1% (18/128) within 15-30 days of each other. Among the 128 dyads, 122 (95%) included 
female members with complete test results for all 6 Ct tests performed in women, and 127 
(99%) included male dyad members with complete test results for all 3 tests performed in 
men.
Quantitative PCR results for members of sexual dyads
Quantitative PCR results were available for 85.4% (82/96) of Ct-infected female dyad 
members; the median endocervical qPCR value was 2,405 IFUde/ml among culture positive 
women (n=75) and 752 IFUde/ml among women who were positive by NAAT-only (n=7) 
(p=0.29). Urethral qPCR results were available for 85.3% (87/102) of Ct-infected male dyad 
members; the median male urethral qPCR result among culture-positive male dyad members 
(n=70) was 659 IFUde/ml, compared with 301 IFUde/ml among NAAT-only positive male 
dyad members (n=17) (p=0.0017).
ompA genotyping of chlamydial infection
We genotyped 166/185 (90%) of Ct-positive participants with specimens available (Table 2). 
We identified 15 variants, 10 that have not been previously reported in the literature. E and F 
strains were the most common in both sites. Ia strains were common in Indianapolis but not 
Schillinger et al. Page 6
Sex Transm Dis. Author manuscript; available in PMC 2017 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
seen in Boston. There were four participants with mixed infection; each of the four was a 
member of a different concordant dyad.
Concordance, and genotype-specific concordance
Overall, 54.7% (70/128) of dyads were concordant for Ct infection. Among 96 female dyad 
members with Ct infection (any test positive at any site), 84 were culture-positive (all 84 
were also NAAT-positive), and 12 were culture negative, but NAAT-positive (Figure). 
Among 96 dyads with female members who were NAAT-positive (with or without a positive 
culture), overall concordance of Ct-infection was 72.9% (70/96). In dyads with female 
members positive by both culture and NAAT, concordance was 78.6% (66/84); among the 51 
of these concordant dyads tested, 49 (96.1%) had identical genotypes. In dyads with culture-
negative, NAAT-positive women, concordance was 33.3% (4/12) and the two concordant 
dyads tested had identical genotypes.
Among 102 male dyad members with Ct infection, all were NAAT-positive; 74 had culture-
positive urethral swabs, and 28 had culture-negative urethral swabs, but NAAT-positive, 
urethral swabs or urine specimens (Figure). Concordance of Ct-infection was 68.6% 
(70/102) overall. In dyads with Ct-culture-positive male members, concordance was 77.0% 
(57/74). Among the 46 concordant dyads with Ct genotyping data available for both 
members, 95.7% (44/46) had identical genotypes. Concordance was 46.4% (13/28) in dyads 
with culture-negative, NAAT-positive male members, and 100% of the 7 concordant dyads 
with genotype information had identical genotypes.
Overall, the same genotype was detected in 96.2% (51/53) of concordant dyads with 
genotype results available.
Factors associated with concordance
Based on high genotype identity (96%) among Ct concordant partnerships tested, we 
included all Ct-concordant dyads in this analysis. No male or female demographic or 
behavioral characteristic was significantly associated with concordance (Table 3). 
Concordance for infection was lower in dyads with infected men who reported 100% 
condom use (52.2% versus 73.3%, OR 0.40, p=0.062) and in dyads with men who reported 
spermicide use (53.9% versus 70.6%, OR 0.49, p=0.23), and was higher in dyads with 
infected men who reported a greater frequency of coital events with the female dyad 
member (median of 10 coital events among concordant dyads versus 6.7 among discordant 
dyads, OR 1.04, p=0.072, or a 4% increase in concordance with each additional coital 
event).
Some biologic findings were associated with concordance (Table 4). In partnerships with a 
Ct-infected man, concordance was less likely if the man was NAAT positive-only ( Ct 
culture negative) compared with those Ct culture positive (46.4% versus 77.1%, OR 0.26, 
p=0.0048). Similarly, in partnerships with a Ct-infected woman, concordance was less likely 
if the woman was NAAT-positive but Ct culture-negative (33.3% versus 77.2%, OR 0.15, 
p=0.0042). Both Ct-infected men and women in concordant dyads had higher median qPCR 
values (male urethral, 656, and female endocervical, 3,032) compared to Ct-infected men 
and -infected women in discordant dyads (male urethral, 372, female endocervical, 1013), 
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however, the association of higher qPCR values with concordance was statistically 
significant only among women (p=0.0067). Concurrent infection with other STI pathogens 
was not significantly associated with concordance for chlamydial infection.
DISCUSSION
In the largest Ct concordance study conducted to date, we observed high rates of 
concordance for Ct infection among the sex partners of Ct NAAT-positive men and women 
(72.9% of male partners, and 68.6% of female partners), rates comparable to those observed 
in other partnership studies that used NAAT [5-9]. We found even higher concordance in 
sexual dyads with culture-positive members (78.6% of male partners and 77.0% of female 
partners).
We also found that sexual dyads with a NAAT-only positive member were less likely to be 
concordant, similar to findings reported by two smaller studies [5,8]. We hypothesize that 
the lower rate of concordance among partners of NAAT-only positive participants (both men 
and women) is related to lower organism load. The lower median qPCR result among 
NAAT-positive only versus culture-positive male and female dyad members supports this 
idea, as does the finding that the odds of concordance was significantly lower in dyads with 
an infected female member who had a lower organism load. Our findings differ from those 
of Gomes et al [22] who reported no difference in the median Ct load measured by qPCR 
performed on urine specimens from men and women in concordant (n=12), and discordant 
(n=28) sexual partnerships. It is also possible that non-viable Ct DNA was detected in 
NAAT-only positive dyad members.
We did not identify any behavioral characteristics significantly associated with a lower 
probability of having a chlamydial infected partner. Taken together with the non-negligible 
(43%) concordance rate we found in dyads with NAAT-only positive members, these data 
confirm that the partners of persons with NAAT-diagnosed Ct should always be presumed 
Ct-infected and efforts made to ensure partner treatment. Partner management strategies 
such as expedited partner therapy, whereby the patient is asked to deliver medication or a 
prescription for medication to their sex partner without an intervening medical evaluation, 
are efficacious and far less resource intensive than traditional partner services, and should be 
utilized when appropriate [35s].
Almost all (96%) the concordant dyads with genotype results had identical genotypes. This 
suggests transmission within the dyad, although certain genotypes (E, F, Ia) common in the 
population could have occurred through sexual contact with a different partner. Multilocus 
sequence typing performed on a subset of 28 dyads from this study where both members had 
identical ompA genotypes; also demonstrated identical strain types [23]. Although not 
definitive, these additional data support transmission within dyads. In addition, the trends we 
found for higher rates of concordance among men reporting lower rates of condom, and 
spermicide use supports this hypothesis; however, transmission cannot be shown definitively 
in a cross sectional study in which not all sex partners are enrolled.
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Concordance studies such as ours have been examined for evidence to support the concept of 
protective immunity to Ct infection [18]. The high rates of concordance that we observed do 
not suggest protective immunity and are comparable to the measured concordance of N. 
gonorrhoeae, an infection that confers little protective immunity because of extensive 
antigenic variation [5,24]. Furthermore we found no difference in concordance by age or 
history of past Ct infection; if previous infection were to provide even partial immunity, 
lower concordance would have been expected in dyads with older members or a history of 
past infection.
Robust estimates of the per coital act transmission probability of Ct can be used to 
understand the risks of re-infection after successful treatment of index cases, and to model 
the requirements for successful control measures. Investigators have used measures of 
concordance of infection within sexual partnerships to estimate Ct transmission rates per 
coital act, but these estimates have relied upon assumptions about coital frequency [25,36s]. 
Our data could be used to model transmission probabilities and could result in improved 
estimates because we collected partner-specific coital frequency data.
This study has a number of limitations. By definition, a cross-sectional concordance study 
cannot demonstrate transmission; in a concordant dyad it is not possible to show which 
partner is the source of infection, and in a discordant dyad it is not possible to know if the 
Ct-negative partner is truly uninfected, as our analysis assumed, or incubating infection, or 
has just cleared a Ct infection. Given the cross-sectional nature of our study, our quantitative 
culture and qPCR results are from single point in time, and it is not possible to know if 
organism burden was increasing, decreasing or remaining stable at the time the specimens 
were collected, nor whether the organism load we measured was similar to that to which the 
dyad member had been exposed. Dyads were restricted to heterosexual sex-partners that we 
located and enrolled, and it is possible that sex partners who were not enrolled differed from 
those who did, possibly affecting true concordance, however, the majority (89%) of study 
enrollees reported only 1 partner in the 30 days before enrollment so any bias resulting from 
excluding additional partners was likely minimal. Dyad members with incomplete test 
results could have been misclassified as uninfected, resulting in an underestimate of 
concordance, however, there were few such instances, so any impact was likely minimal. 
This might have resulted in misclassification, such that we have over- or under-estimated the 
association between organism load and concordance. We used ompA genotyping, a standard 
biomarker, to assign genotype; while not as informative as multilocus strain typing or whole 
genome sequencing, ompA genotype identity nevertheless establishes the plausibility of 
transmission within the partnership. Testing of multiple anatomic sites and specimen types 
may have increased the likelihood of positive tests but NAATs are highly specific and the 
populations studied were at high-risk for STDs, which together would have minimized false-
positive results. Although dyad members who enrolled on different days would have had 
fewer than 30 days of overlap in their recall periods, we analyzed all of the sexual events 
reported by each dyad member with the other member in their respective 30 day recall 
periods, which may have resulted in some misclassification. We did not measure markers of 
mucosal or systemic immunity, which may influence susceptibility to acquisition of 
infection. We used culture to detect GC; if GC NAATs had been used a different association 
between GC infection and Ct concordance may have been observed. Finally, while none of 
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the behavioral factors we examined were associated with significantly higher, or lower odds 
of concordance, we had limited power to detect significant associations for all the variables 
we examined.
In summary, we found high concordance rates of Ct infection in sexual dyads. Concordance 
studies cannot be interpreted as a proxy for transmission studies, however, our genotyping 
data suggested that concordance represented sexual transmission within dyads, and the 
qPCR data suggest that female dyad members with high organism loads may be more likely 
to transmit. Despite having examined numerous behavioral and microbiologic factors likely 
to influence concordance, we did not find any that indicated a way to prioritize partner 
notification, underscoring the need for effective and efficient strategies to identify and treat 
all sex partners exposed to Ct.
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Short Summary
We found high rates of same-genotype Chlamydia trachomatis infection in heterosexual 
partnerships; among women, higher chlamydial organism load was associated with 
chlamydial infection among their male partners.
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Figure. 
Chlamydia trachomatis infection among participants in 128 dyads enrolled in a cross-
sectional study of chlamydial concordance in Boston, and Indianapolis, 2000-2003. Figure 
on left displays dyads with an infected female and their male sex partners. Figure on right 
displays dyads with an infected male and their female sex partners. Individual boxes for sex 
partners include overall infection concordance and the proportion of concordant dyads with 
identical ompA genotype.
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Table 1
Enrollment characteristics of males and females contributing to 128 sexual dyads enrolled in a cross-sectional 
study of chlamydial concordance in Boston and Indianapolis, during 2000-2003
Males Females
Characteristic n (%) n (%)
Total 125 121
Age, years, median (range) 21.1 [15.1, 38.7] 19.8 [14.4, 40.2]
Race/ethnicity
        White non-Hispanic 12 (9.6) 24 (19.8)
        Black non-Hispanic 93 (74.4) 77 (63.6)
        Hispanic 10 (8.0) 12 (9.9)
        Other 10 (8.0) 8 (6.6)
Site enrolled
        STD clinic 78 (62.4) 77 (63.6)
        Adolescent clinic 47 (37.6) 44 (36.4)
Lifetime number of sex partners, median (range) 14 [1, 230] 7 [1, 50]
Sex partners past 60 days,(number)
        1 76 (60.8) 90 (74.4)
        2-5 47 (37.6) 31 (25.6)
        6-10 1 (0.8) 0 (0)
        >10 1 (0.8) 0 (0)
>1 sex partner, past 30 days 19 (15.2) 8 (6.6)
Coital frequency, past 30 days, median (range)b 7 [1, 62] 8 [1, 65]
STI history
        Chlamydia 36 (29.5) 56 (46.3)
        Gonorrhea 28 (22.8) 31 (25.6)
        Trichomoniasis 6 (4.8) 18 (14.9)
        Syphilis 2 (1.6) 1 (0.8)
STI at enrollment
        Chlamydia 99 (79.2) 86 (71.1)
        Gonorrhea 12 (9.6) 13 (10.7)
        Trichomoniasis 6 (4.8) 27 (22.3)
Current oral contraceptive use -- -- 40 (33.1)
a
 Measures frequency of coitus with any partner; not limited to coitus with an enrolled dyad member
Sex Transm Dis. Author manuscript; available in PMC 2017 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Schillinger et al. Page 16
Table 2
ompA genotypes identified among the members of 128 sexual dyads enrolled in a cross-sectional study of 
chlamydial concordance in Boston and Indianapolis, during 2000-2003
Genotypea No. of Participants Boston
No. of Participants 
Indianapolis Representative Strain
b GenBank Accession No. Citation
D 0 6 B120 X62918 [26]
D1 0 2 IU-FW0353 FJ261929 [18]
D2 8 5 IU-FQ0213 FJ261926 [18]
D6 0 1 IU-TC0272ut FJ261943.1 [Variant not previously 
described
D7 0 1 IU-FQ2468 FJ752554 [18]
D11 0 1 IU-TC0319ut FJ261942.1 Variant not previously 
described
D12 0 2 IU-FW4101 FJ261933 [18]
D14 1 0 BT210182 FJ261952.1 Variant not previously 
described
E 19 40 UW5 X52557 [27]
E4 2 0 IU-TC0865ur FJ261949.1 Variant not previously 
described
E5 0 1 IU-TC0426cx FJ261946.1 Variant not previously 
described
E6 0 2 IU-TC0755ut FJ261948.1 Variant not previously 
described
E7 4 0 BT210178 FJ261953.1 Variant not previously 
described
F 13 19 IC-Cal3 X52080 [28]
G 1 0 UW57 AF063199 [19]
G3 1 0 BT210142 FJ261954.1 Variant not previously 
described
H 0 2 UW4 X16007 [29]
Ia 0 13 IU-4168 AF063201 [19]
Ia1 1 1 IU-TC0018ut FJ261940.1 Variant not previously 
described
J 2 5 UW36 AF063202 [19]
J4 2 0 BT110254ut FJ261951.1 Variant not previously 
described
Ja1 2 0 IU-FW4076 FJ261932 [18]
K 0 5 UW31 AF056204 [19]
Mixed 0 4c
Total 56 110
aGenotypes identical to prototype strains shown as letters and variants thereof are numbered. Sequences of numbered variants E4, E5, E6 and E7 
do not correspond to any numbered E variants previously described [30].
bSpecific strains for which sequences are accessible in GenBank.
c
Participants with mixed infections; all four were members of concordant dyads: (male, D6, female D/F; male E, female E/H; male, F/K, female, F; 
male, D/I, female, Ia).
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